SpringWorks Therapeutics Key Fundamental Indicators
| SWTXDelisted Stock | USD 46.99 0.00 0.00% |
As of the 18th of February 2026, SpringWorks Therapeutics has the Risk Adjusted Performance of 0.0242, coefficient of variation of 4771.39, and Semi Deviation of 2.82. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of SpringWorks Therapeutics, as well as the relationship between them.
SpringWorks Therapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing SpringWorks Therapeutics' valuation are provided below:SpringWorks Therapeutics does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. SpringWorks |
Search Suggestions
| SW | Smurfit WestRock plc | Company |
| SWZ | Swiss Helvetia Closed | Fund |
| SWP | SWP Growth Income | ETF |
| SWRV | SWRV | Cryptocurrency |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, SpringWorks Therapeutics has a Return On Equity of -0.5157. This is 97.85% lower than that of the Biotechnology sector and 98.59% lower than that of the Health Care industry. The return on equity for all United States stocks is 66.35% higher than that of the company.
SpringWorks Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining SpringWorks Therapeutics's current stock value. Our valuation model uses many indicators to compare SpringWorks Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SpringWorks Therapeutics competition to find correlations between indicators driving SpringWorks Therapeutics's intrinsic value. More Info.SpringWorks Therapeutics is rated third in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SpringWorks Therapeutics' earnings, one of the primary drivers of an investment's value.SpringWorks Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SpringWorks Therapeutics' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SpringWorks Therapeutics could also be used in its relative valuation, which is a method of valuing SpringWorks Therapeutics by comparing valuation metrics of similar companies.SpringWorks Therapeutics is currently under evaluation in return on equity category among its peers.
SpringWorks Fundamentals
| Return On Equity | -0.52 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (1.16) % | |||
| Operating Margin | (1.64) % | |||
| Current Valuation | 3.26 B | |||
| Shares Outstanding | 75.35 M | |||
| Shares Owned By Insiders | 1.20 % | |||
| Shares Owned By Institutions | 87.40 % | |||
| Number Of Shares Shorted | 6.38 M | |||
| Price To Earning | 6.14 X | |||
| Price To Book | 8.49 X | |||
| Price To Sales | 16.12 X | |||
| Revenue | 191.59 M | |||
| Gross Profit | 204.8 M | |||
| EBITDA | (278.13 M) | |||
| Net Income | (258.13 M) | |||
| Cash And Equivalents | 334.54 M | |||
| Cash Per Share | 6.81 X | |||
| Total Debt | 7.91 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 9.80 X | |||
| Book Value Per Share | 5.57 X | |||
| Cash Flow From Operations | (175.6 M) | |||
| Short Ratio | 1.46 X | |||
| Earnings Per Share | (3.41) X | |||
| Target Price | 47.0 | |||
| Number Of Employees | 368 | |||
| Beta | 0.7 | |||
| Market Capitalization | 3.54 B | |||
| Total Asset | 587.28 M | |||
| Retained Earnings | (1.15 B) | |||
| Working Capital | 280.48 M | |||
| Current Asset | 29.13 M | |||
| Current Liabilities | 10.16 M | |||
| Net Asset | 587.28 M |
About SpringWorks Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SpringWorks Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SpringWorks Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SpringWorks Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. SpringWorks Therapeutics, Inc. was founded in 2017 and is headquartered in Stamford, Connecticut. Springworks Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 207 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in SpringWorks Stock
If you are still planning to invest in SpringWorks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SpringWorks Therapeutics' history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |